当前位置:
X-MOL 学术
›
Aliment. Pharm. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Editorial: choosing an appropriate risk stratification tool for nonalcoholic fatty liver disease-one size does not fit all. Authors' reply.
Alimentary Pharmacology & Therapeutics ( IF 7.6 ) Pub Date : 2020-03-01 , DOI: 10.1111/apt.15651 Dae Won Jun 1 , Mindie H Nguyen 2
中文翻译:
社论:为非酒精性脂肪肝疾病选择合适的风险分层工具-一种规模并不适合所有人。作者的答复。
更新日期:2020-03-01
Alimentary Pharmacology & Therapeutics ( IF 7.6 ) Pub Date : 2020-03-01 , DOI: 10.1111/apt.15651 Dae Won Jun 1 , Mindie H Nguyen 2
Affiliation
中文翻译:
社论:为非酒精性脂肪肝疾病选择合适的风险分层工具-一种规模并不适合所有人。作者的答复。